Gastrointestinal Dysfunction Impact on Life Quality in a Cohort of Russian Patients with Parkinson’s Disease I‐III H&Y Stage
Open Access
- 1 January 2022
- journal article
- research article
- Published by Wiley in Parkinson's Disease
- Vol. 2022 (1) , 1571801
Abstract
Background. There are still no clearly proven methods to slow down or stop the progression of Parkinson’s disease (PD). Thus, improving the quality of life (QoL) of patients with PD becomes of primary importance. Autonomic dysfunction and its symptoms are known to worsen the quality of life in PD, but the degree of this influence is underinvestigated. Particularly, impacts of the separate significant gastrointestinal symptoms, such as dyspepsia, constipation, and abdominal pain, in PD should be more precisely evaluated with the help of specific scales. Objective. To assess the impacts of gastrointestinal dysfunction and its symptoms on PD patient’s QoL using PDQ‐39. Methods. 111 PD patients in the I‐III Hoehn and Yahr (H&Y) stage were enrolled in the study. The following scales were applied: UPDRS III, PDQ‐39, GSRS, GDSS, MMSE, BDI, STAI‐S, and STAI‐T. Results. The linear regression model showed that the PDQ‐39 SI depended on summary assessments GSRS‐SI (β = 0.333, p < 0.001), BDI (β = 0.463, p < 0.001), and UPDRS III (β = 0.163, p < 0.05). The use of the stepwise method, adding GSRS‐SI and UPDRS III scores to the BDI predictor, improved the model (R2 increased from 0.454 to 0.574). The investigation of GSRS domain’s influence revealed that PDQ‐39 SI had a significant correlation with almost all of them, but the regression analysis showed significant QoL impacts of only two factors: constipation and abdominal pain (β = 0.288, p < 0.01 and β = 0.243, p < 0.05 accordingly). Conclusions. Our results suggest a considerable negative influence of depression and gastrointestinal dysfunction (especially constipation and abdominal pain) on QoL of patients with PD. Their impact on QoL in patients with I‐III H&Y stages of PD is more significant than that of motor symptoms. Therefore, the correction of depression and gastrointestinal dysfunction should be prioritized in PD therapy.Keywords
This publication has 35 references indexed in Scilit:
- Nonmotor versus motor symptoms: How much do they matter to health status in Parkinson's disease?Movement Disorders, 2011
- Determinants of health-related quality of life in Parkinson’s disease: A systematic reviewParkinsonism & Related Disorders, 2011
- Nonmotor symptoms are independently associated with impaired health‐related quality of life in Chinese patients with Parkinson's diseaseMovement Disorders, 2010
- Reliability and validity of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in dyspepsia: A six-country studyHealth and Quality of Life Outcomes, 2008
- The 39 item Parkinson's disease questionnaire (PDQ-39) revisited: implications for evidence based medicineJournal of Neurology, Neurosurgery & Psychiatry, 2007
- Assessment of outcome in dyspepsia: has progress been made?Gut, 2002
- The Glasgow Dyspepsia Severity Score ??? a tool for the global measurement of dyspepsiaEuropean Journal of Gastroenterology & Hepatology, 1996
- Relevance of Norm Values as Part of the Documentation of Quality of Life Instruments for Use in Upper Gastrointestinal DiseaseScandinavian Journal of Gastroenterology, 1996
- Frequency of Constipation in Major DepressionPsychosomatics, 1990
- The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1988